You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nonmyeloablative

Showing 1 - 25 of 310
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Aug 22, 2022

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
Has Results
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)

Completed
Has Results
  • Acute Leukemia
  • +4 more
  • Atlanta, Georgia
    Northside Hospital
Sep 1, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Type 1 Diabetes Trial in Shanghai (AHSCT, Insulin therapy)

Completed
  • Type 1 Diabetes Mellitus
  • AHSCT
  • Insulin therapy
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine
Nov 16, 2021

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022

Sickle Cell Disease and Thalassemia Trial in Dallas (Donor Stem Cell Transplantation)

Withdrawn
  • Sickle Cell Disease and Thalassemia
  • Donor Stem Cell Transplantation
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 22, 2021

Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

Recruiting
  • Hematologic Neoplasms
  • Milan, Italy
    European Institute of Oncology
Sep 24, 2021

Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

Completed
Has Results
  • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
  • Severe Aplastic Anemia (SAA)
  • Umbilical Cord Blood
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 16, 2021

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
Jun 1, 2021

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

Terminated
  • Leukemia, Myeloid, Acute
  • +8 more
  • Mesenchymal stem cells
  • Isotonic solution
  • Edeghem, Antwerpen, Belgium
  • +9 more
Aug 31, 2021